Hemolytic anemia natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hemolytic anemia}}
{{Hemolytic anemia}}
{{CMG}}
{{CMG}} {{shyam}}


==Overview==
==Overview==


==Natural History==
==Natural History==
The natural history depends on the etiology of the hemolytic anemia.
*'''Drug-induced hemolytic anemia''' tends to be transient, if the etiology is identified. Once the drug is introduced, the hemolysis typically begins within a few days. Once the offending agent is discontinued, the hemolysis begins to abate. There are typically no long-term complications from this type of hemolysis.
*'''Hereditary etiologies of hemolytic anemia,''' such as G6PD deficiency, red blood cell membrane defects, or red blood cell enzyme defects, tend to manifest with lifelong symptoms, as these are difficult to cure. Patients with these types of hemolytic anemia have lifelong risk.


==Complications==
==Complications==
Line 20: Line 24:
==Prognosis==
==Prognosis==
The outcome depends on the type and cause of hemolytic anemia.
The outcome depends on the type and cause of hemolytic anemia.
*Drug-induced hemolytic anemia: The prognosis of this type of anemia is typically favorable if the offending agent is discontinued.


==References==
==References==

Revision as of 02:30, 16 October 2017

Hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI Scan

Echocardiography or Ultrasound

Imaging Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic anemia natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic anemia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic anemia natural history, complications and prognosis

CDC on Hemolytic anemia natural history, complications and prognosis

Hemolytic anemia natural history, complications and prognosis in the news

Blogs on Hemolytic anemia natural history, complications and prognosis

Directions to Hospitals Treating Hemolytic anemia

Risk calculators and risk factors for Hemolytic anemia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Overview

Natural History

The natural history depends on the etiology of the hemolytic anemia.

  • Drug-induced hemolytic anemia tends to be transient, if the etiology is identified. Once the drug is introduced, the hemolysis typically begins within a few days. Once the offending agent is discontinued, the hemolysis begins to abate. There are typically no long-term complications from this type of hemolysis.
  • Hereditary etiologies of hemolytic anemia, such as G6PD deficiency, red blood cell membrane defects, or red blood cell enzyme defects, tend to manifest with lifelong symptoms, as these are difficult to cure. Patients with these types of hemolytic anemia have lifelong risk.

Complications

The complications depend on the specific type of hemolytic anemia.

  • Severe anemia can cause cardiovascular collapse (failure of the heart and blood pressure, leading to death).
  • Severe anemias can exacerbate heart disease, lung disease, or cerebrovascular disease.
  • Severe anemia can result in transfusion dependence, in which a patient requires ongoing blood transfusions with packed red blood cells. Complications of transfusion include:
    • Transfusion-associated circulatory overload (TACO)
    • Transfusion-related acute lung injury (TRALI)
    • Iron overload, or hemosiderosis
    • Transfusion reaction due to ABO blood group incompatibility

Prognosis

The outcome depends on the type and cause of hemolytic anemia.

  • Drug-induced hemolytic anemia: The prognosis of this type of anemia is typically favorable if the offending agent is discontinued.


References

Template:WS Template:WH